Table 3 CNV classification using ACMG/ClinGen framework.
Family | Diagnosis | CNV class | Clinically relevant gene | Interpretation of CNV | ACMG/ClinGen Criteria (score) | Total Score | Classification |
---|---|---|---|---|---|---|---|
CMD | HCM | Intergenic deletion | MYBPC3 | ClinGen haploinsufficiency score 3; nonspecific phenotype consistent with similar cases | 2D-4 (0.9) 5G (0.1) | 1.0 | Pathogenic |
NSW76A | SUD | Intergenic deletion | KCNH2 | ClinGen haploinsufficiency score 3; nonspecific phenotype consistent with similar cases | 2A (1.0) 5G (0.1) | 1.1 | Pathogenic |
CBD | DCM | Intragenic deletion | TTN | De novo truncating variant in our patient and in literature; truncating variant burden in DCM; multiple segregations reported for truncating variants | 4C (0.1) 4M (0.45) 4H (0.45) 5A (0.15) | 1.15 | Pathogenic |
AHM | LVNC | Intragenic deletion | ACTN2 | Truncating variant burden in LVNC; nonspecific phenotype consistent with similar cases | 4M (0.3) 5G (0.1) | 0.4 | VUS |
AYQ | HCM | Tandem partial-gene duplication | MYH7 | Similarly affected family members with 7 segregations; nonspecific phenotype consistent with similar cases | 4H (0.45) 5G (0.1) | 0.55 | VUS |
CBT | LVNC | Duplication | RBM20 | Truncating variant burden in LVNC; nonspecific phenotype consistent with similar cases | 4M (0.3) 5G (0.1) | 0.4 | VUS |
BLX | LQTS | Duplication | PLN | No supporting criteria | NA | 0 | VUS |
CIJ | DCM | Intragenic deletion | CTNNA3 | Overlap with common population variation | 4O (−1.0) | −1 | Benign |